Share this article Share this article NEW YORK, April 22, 2021 /PRNewswire/ -- Cancer research and development are a major part of the biotechnology industry, and there is always room for improvement and growth. Recently, biotech company Perimeter Medical Imaging Al (TSXV: PINK) (OTC: PYNKF) revealed a revolutionary way for surgeons to be able to assess if a cancer has been fully removed, while still in the operating room. Syndax Pharmaceuticals (NASDAQ: SNDX), Nektar Therapeutics (NASDAQ: NKTR), SELLAS Life Sciences Group (NASDAQ: SLS), and Celldex Therapeutics (NASDAQ: CLDX) are also l...